ArticleMolecular and clinical oncology2016

Evaluation of a trastuzumab-containing treatment regimen for patients with unresectable advanced or recurrent gastric cancer.

Tsutomu Namikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.